CAS 1279033-05-4

BENAZEPRILAT-D5

Description:

Benazeprilat-D5 is a deuterated form of benazeprilat, which is the active metabolite of the antihypertensive drug benazepril, an angiotensin-converting enzyme (ACE) inhibitor. The deuteration in Benazeprilat-D5 involves the substitution of hydrogen atoms with deuterium, which can enhance the stability and metabolic tracking of the compound in pharmacokinetic studies. This substance is primarily used in research settings to study the pharmacodynamics and pharmacokinetics of benazepril without interference from the natural isotopic composition of hydrogen. Benazeprilat itself works by inhibiting the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced blood pressure. The characteristics of Benazeprilat-D5 include its molecular structure, which retains the functional groups necessary for ACE inhibition, while the presence of deuterium may alter its physical properties slightly compared to its non-deuterated counterpart. As with many pharmaceutical compounds, safety and handling precautions are essential when working with Benazeprilat-D5 in laboratory settings.

Formula: C₂₂H₁₉D₅N₂O₅

Synonyms:

• BENAZEPRILAT-D5
• (3S)-3-[[(1S)-1-Carboxy-3-phenylpropyl]aMino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic Acid-d5

Benazepril EP Impurity C-d5 (Benazepril USP Related Compound C-d5, Benazeprilat-d5)

CAS: 1279033-05-4

Formula: C₂₂H₁₉D₅N₂O₅

Color and Shape: White To Off-White Solid

Molecular weight: 401.47

Ref: 4Z-B-014

Benazeprilat-d5

Controlled Product

CAS: 1279033-05-4

Formula: C₂₂H₁₉D₅N₂O₅

Color and Shape: Neat

Molecular weight: 401.47

Ref: TR-B119762

Benazeprilat-d5

CAS: 1279033-05-4

Benazeprilat-d5 is an inhibitor that can be used in the treatment of cancer. It has been shown to induce apoptosis in cancer cells and has anticancer properties. This drug is a kinase analog inhibitor that targets specific proteins involved in tumor growth and proliferation. Studies have shown that Benazeprilat-d5 inhibits Chinese hamster ovary cell proliferation and reduces the activity of various kinases involved in cancer cell growth. It is excreted primarily through urine in humans, making it a safe and effective treatment option for those suffering from cancer. Additionally, Benazeprilat-d5 has been found to enhance the effects of other anticancer drugs such as octreotide, making it a promising new therapy for cancer patients.

Formula: C₂₂H₂₄N₂O₅

Purity: Min. 95%

Molecular weight: 401.5 g/mol

Ref: 3D-EBC03305